SELECTION OF N-(PHOSPHONACETYL)-L-ASPARTATE RESISTANT CHINESE-HAMSTER MUTANTS IN THE PRESENCE OF THE URIDINE UPTAKE INHIBITOR DIPYRIDAMOLE

被引:0
|
作者
TESSERA, L [1 ]
MUCCIOLO, E [1 ]
BERTONI, L [1 ]
GIULOTTO, E [1 ]
机构
[1] UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL A BUZZATI TRAV,I-27100 PAVIA,ITALY
关键词
PALA; DIPYRIDAMOLE; GENE AMPLIFICATION; DRUG RESISTANCE; CHINESE HAMSTER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In mammalian cells selected in culture for resistance to PALA the CAD gene is amplified and these cells are a widely used model system to study gene amplification. Selection of resistant mutants is routinely performed in medium supplemented with dialyzed serum, because the cytotoxic effect of PALA is reversed by uridine, which is contained in serum. We have shown that in Chinese hamster cells dipyridamole reduced uridine uptake to less than 5% with limited effect on cell survival. Moreover, in medium supplemented with complete serum and 10 mu M dipyridamole the toxicity of PALA was similar to that obtained in medium containing dialyzed serum. We then used 10 mu M dipyridamole to inhibit uridine uptake during selection of PALA resistant colonies and found that both the frequency and the type of mutants were as those obtained in the presence of dialyzed serum. In particular, in the five mutants tested, the mechanism of resistance of PALA was amplification of the CAD gene.
引用
收藏
页码:189 / 192
页数:4
相关论文
共 2 条
  • [1] N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma
    Grem, JL
    Yee, LK
    Schuler, B
    Hamilton, JM
    Chen, AP
    Chabuk, C
    Grollman, F
    Grabenc, M
    Allegra, CJ
    Takimoto, CH
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1581 - 1587
  • [2] Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers
    Lelais, Gerald
    Epple, Robert
    Marsilje, Thomas H.
    Long, Yun O.
    McNeill, Matthew
    Chen, Bei
    Lu, Wenshuo
    Anumolu, Jaganmohan
    Badiger, Sangamesh
    Bursulaya, Badry
    DiDonato, Michael
    Fong, Rina
    Juarez, Jose
    Li, Jie
    Manuia, Mari
    Mason, Daniel E.
    Gordon, Perry
    Groessl, Todd
    Johnson, Kevin
    Jia, Yong
    Kasibhatla, Shailaja
    Li, Chun
    Isbell, John
    Spraggon, Glen
    Bender, Steven
    Michellys, Pierre-Yves
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6671 - 6689